Global Targeted Radiopharmaceuticals Market Research Report 2025(Status and Outlook)
Report Overview
Targeted Radiopharmaceuticals are a specialized class of medical compounds that combine the properties of radiopharmaceuticals and molecular targeting agents. These compounds are designed to selectively deliver radioactive isotopes to specific cells or tissues within the body, particularly those associated with diseases such as cancer. The "targeting" aspect refers to the molecule's ability to bind to unique receptors or antigens expressed on the surface of diseased cells, ensuring that the radioactive payload is delivered precisely to the intended site. This targeted approach aims to maximize the therapeutic effect while minimizing damage to healthy tissues, thus potentially improving treatment outcomes and reducing side effects. The development and application of targeted radiopharmaceuticals involve interdisciplinary expertise, including nuclear medicine, molecular biology, and radiochemistry, and they represent an advanced area in the field of personalized and precision medicine.
In 2024, the global Targeted Radiopharmaceuticals market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global Targeted Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Targeted Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Targeted Radiopharmaceuticals market in any manner.
Global Targeted Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Bayer
Lantheus
Institute for Radioelements (IRE)
Radiomedix
Curium Pharma
Clarity Pharmaceuticals
ROTOP
Ratio Therapeutics
Fusion Pharmaceuticals
Perspective Therapeutics
RayzeBio
Alpha-9 Theranostics
Radiopharm Theranostics
Telix Pharmaceuticals
Ariceum Therapeutics
Aktis Oncology
Navidea Biopharmaceuticals
Nucleus RadioPharma
SmartNuclide Biopharma
TetraKit Technologies
Market Segmentation (by Type)
Targeted Therapeutic Radiopharmaceuticals
Targeted Diagnostic Radiopharmaceuticals
Market Segmentation (by Application)
Targeted Therapy
Targeted Diagnosis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Targeted Radiopharmaceuticals Market
Overview of the regional outlook of the Targeted Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Targeted Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Targeted Radiopharmaceuticals are a specialized class of medical compounds that combine the properties of radiopharmaceuticals and molecular targeting agents. These compounds are designed to selectively deliver radioactive isotopes to specific cells or tissues within the body, particularly those associated with diseases such as cancer. The "targeting" aspect refers to the molecule's ability to bind to unique receptors or antigens expressed on the surface of diseased cells, ensuring that the radioactive payload is delivered precisely to the intended site. This targeted approach aims to maximize the therapeutic effect while minimizing damage to healthy tissues, thus potentially improving treatment outcomes and reducing side effects. The development and application of targeted radiopharmaceuticals involve interdisciplinary expertise, including nuclear medicine, molecular biology, and radiochemistry, and they represent an advanced area in the field of personalized and precision medicine.
In 2024, the global Targeted Radiopharmaceuticals market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global Targeted Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Targeted Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Targeted Radiopharmaceuticals market in any manner.
Global Targeted Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Bayer
Lantheus
Institute for Radioelements (IRE)
Radiomedix
Curium Pharma
Clarity Pharmaceuticals
ROTOP
Ratio Therapeutics
Fusion Pharmaceuticals
Perspective Therapeutics
RayzeBio
Alpha-9 Theranostics
Radiopharm Theranostics
Telix Pharmaceuticals
Ariceum Therapeutics
Aktis Oncology
Navidea Biopharmaceuticals
Nucleus RadioPharma
SmartNuclide Biopharma
TetraKit Technologies
Market Segmentation (by Type)
Targeted Therapeutic Radiopharmaceuticals
Targeted Diagnostic Radiopharmaceuticals
Market Segmentation (by Application)
Targeted Therapy
Targeted Diagnosis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Targeted Radiopharmaceuticals Market
Overview of the regional outlook of the Targeted Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Targeted Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Targeted Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Targeted Radiopharmaceuticals Segment by Type
1.2.2 Targeted Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Targeted Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Targeted Radiopharmaceuticals Product Life Cycle
3.3 Global Targeted Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Targeted Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Targeted Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Targeted Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Targeted Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Targeted Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Targeted Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TARGETED RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Targeted Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Targeted Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Targeted Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 TARGETED RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Targeted Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Targeted Radiopharmaceuticals Price by Type (2020-2025)
7 TARGETED RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Targeted Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 TARGETED RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Targeted Radiopharmaceuticals Sales by Region
8.1.1 Global Targeted Radiopharmaceuticals Sales by Region
8.1.2 Global Targeted Radiopharmaceuticals Sales Market Share by Region
8.2 Global Targeted Radiopharmaceuticals Market Size by Region
8.2.1 Global Targeted Radiopharmaceuticals Market Size by Region
8.2.2 Global Targeted Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Targeted Radiopharmaceuticals Sales by Country
8.3.2 North America Targeted Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Targeted Radiopharmaceuticals Sales by Country
8.4.2 Europe Targeted Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Targeted Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Targeted Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Targeted Radiopharmaceuticals Sales by Country
8.6.2 South America Targeted Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Targeted Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Targeted Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TARGETED RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Targeted Radiopharmaceuticals by Region(2020-2025)
9.2 Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Targeted Radiopharmaceuticals Production
9.4.1 North America Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Targeted Radiopharmaceuticals Production
9.5.1 Europe Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Targeted Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Targeted Radiopharmaceuticals Production (2020-2025)
9.7.1 China Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Targeted Radiopharmaceuticals Product Overview
10.1.3 Novartis Targeted Radiopharmaceuticals Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Targeted Radiopharmaceuticals Product Overview
10.2.3 Bayer Targeted Radiopharmaceuticals Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Targeted Radiopharmaceuticals Product Overview
10.3.3 Lantheus Targeted Radiopharmaceuticals Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 Institute for Radioelements (IRE)
10.4.1 Institute for Radioelements (IRE) Basic Information
10.4.2 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Overview
10.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Market Performance
10.4.4 Institute for Radioelements (IRE) Business Overview
10.4.5 Institute for Radioelements (IRE) Recent Developments
10.5 Radiomedix
10.5.1 Radiomedix Basic Information
10.5.2 Radiomedix Targeted Radiopharmaceuticals Product Overview
10.5.3 Radiomedix Targeted Radiopharmaceuticals Product Market Performance
10.5.4 Radiomedix Business Overview
10.5.5 Radiomedix Recent Developments
10.6 Curium Pharma
10.6.1 Curium Pharma Basic Information
10.6.2 Curium Pharma Targeted Radiopharmaceuticals Product Overview
10.6.3 Curium Pharma Targeted Radiopharmaceuticals Product Market Performance
10.6.4 Curium Pharma Business Overview
10.6.5 Curium Pharma Recent Developments
10.7 Clarity Pharmaceuticals
10.7.1 Clarity Pharmaceuticals Basic Information
10.7.2 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.7.4 Clarity Pharmaceuticals Business Overview
10.7.5 Clarity Pharmaceuticals Recent Developments
10.8 ROTOP
10.8.1 ROTOP Basic Information
10.8.2 ROTOP Targeted Radiopharmaceuticals Product Overview
10.8.3 ROTOP Targeted Radiopharmaceuticals Product Market Performance
10.8.4 ROTOP Business Overview
10.8.5 ROTOP Recent Developments
10.9 Ratio Therapeutics
10.9.1 Ratio Therapeutics Basic Information
10.9.2 Ratio Therapeutics Targeted Radiopharmaceuticals Product Overview
10.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.9.4 Ratio Therapeutics Business Overview
10.9.5 Ratio Therapeutics Recent Developments
10.10 Fusion Pharmaceuticals
10.10.1 Fusion Pharmaceuticals Basic Information
10.10.2 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.10.4 Fusion Pharmaceuticals Business Overview
10.10.5 Fusion Pharmaceuticals Recent Developments
10.11 Perspective Therapeutics
10.11.1 Perspective Therapeutics Basic Information
10.11.2 Perspective Therapeutics Targeted Radiopharmaceuticals Product Overview
10.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.11.4 Perspective Therapeutics Business Overview
10.11.5 Perspective Therapeutics Recent Developments
10.12 RayzeBio
10.12.1 RayzeBio Basic Information
10.12.2 RayzeBio Targeted Radiopharmaceuticals Product Overview
10.12.3 RayzeBio Targeted Radiopharmaceuticals Product Market Performance
10.12.4 RayzeBio Business Overview
10.12.5 RayzeBio Recent Developments
10.13 Alpha-9 Theranostics
10.13.1 Alpha-9 Theranostics Basic Information
10.13.2 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Overview
10.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Market Performance
10.13.4 Alpha-9 Theranostics Business Overview
10.13.5 Alpha-9 Theranostics Recent Developments
10.14 Radiopharm Theranostics
10.14.1 Radiopharm Theranostics Basic Information
10.14.2 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Overview
10.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Market Performance
10.14.4 Radiopharm Theranostics Business Overview
10.14.5 Radiopharm Theranostics Recent Developments
10.15 Telix Pharmaceuticals
10.15.1 Telix Pharmaceuticals Basic Information
10.15.2 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.15.4 Telix Pharmaceuticals Business Overview
10.15.5 Telix Pharmaceuticals Recent Developments
10.16 Ariceum Therapeutics
10.16.1 Ariceum Therapeutics Basic Information
10.16.2 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Overview
10.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.16.4 Ariceum Therapeutics Business Overview
10.16.5 Ariceum Therapeutics Recent Developments
10.17 Aktis Oncology
10.17.1 Aktis Oncology Basic Information
10.17.2 Aktis Oncology Targeted Radiopharmaceuticals Product Overview
10.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product Market Performance
10.17.4 Aktis Oncology Business Overview
10.17.5 Aktis Oncology Recent Developments
10.18 Navidea Biopharmaceuticals
10.18.1 Navidea Biopharmaceuticals Basic Information
10.18.2 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.18.4 Navidea Biopharmaceuticals Business Overview
10.18.5 Navidea Biopharmaceuticals Recent Developments
10.19 Nucleus RadioPharma
10.19.1 Nucleus RadioPharma Basic Information
10.19.2 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Overview
10.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Market Performance
10.19.4 Nucleus RadioPharma Business Overview
10.19.5 Nucleus RadioPharma Recent Developments
10.20 SmartNuclide Biopharma
10.20.1 SmartNuclide Biopharma Basic Information
10.20.2 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Overview
10.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Market Performance
10.20.4 SmartNuclide Biopharma Business Overview
10.20.5 SmartNuclide Biopharma Recent Developments
10.21 TetraKit Technologies
10.21.1 TetraKit Technologies Basic Information
10.21.2 TetraKit Technologies Targeted Radiopharmaceuticals Product Overview
10.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product Market Performance
10.21.4 TetraKit Technologies Business Overview
10.21.5 TetraKit Technologies Recent Developments
11 TARGETED RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Targeted Radiopharmaceuticals Market Size Forecast
11.2 Global Targeted Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Targeted Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Targeted Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Targeted Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Targeted Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Targeted Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Targeted Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Targeted Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Targeted Radiopharmaceuticals by Type (2026-2033)
12.2 Global Targeted Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Targeted Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Targeted Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Targeted Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Targeted Radiopharmaceuticals Segment by Type
1.2.2 Targeted Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Targeted Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Targeted Radiopharmaceuticals Product Life Cycle
3.3 Global Targeted Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Targeted Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Targeted Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Targeted Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Targeted Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Targeted Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Targeted Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TARGETED RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Targeted Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Targeted Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Targeted Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 TARGETED RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Targeted Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Targeted Radiopharmaceuticals Price by Type (2020-2025)
7 TARGETED RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Targeted Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 TARGETED RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Targeted Radiopharmaceuticals Sales by Region
8.1.1 Global Targeted Radiopharmaceuticals Sales by Region
8.1.2 Global Targeted Radiopharmaceuticals Sales Market Share by Region
8.2 Global Targeted Radiopharmaceuticals Market Size by Region
8.2.1 Global Targeted Radiopharmaceuticals Market Size by Region
8.2.2 Global Targeted Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Targeted Radiopharmaceuticals Sales by Country
8.3.2 North America Targeted Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Targeted Radiopharmaceuticals Sales by Country
8.4.2 Europe Targeted Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Targeted Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Targeted Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Targeted Radiopharmaceuticals Sales by Country
8.6.2 South America Targeted Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Targeted Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Targeted Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TARGETED RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Targeted Radiopharmaceuticals by Region(2020-2025)
9.2 Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Targeted Radiopharmaceuticals Production
9.4.1 North America Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Targeted Radiopharmaceuticals Production
9.5.1 Europe Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Targeted Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Targeted Radiopharmaceuticals Production (2020-2025)
9.7.1 China Targeted Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Targeted Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Targeted Radiopharmaceuticals Product Overview
10.1.3 Novartis Targeted Radiopharmaceuticals Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Targeted Radiopharmaceuticals Product Overview
10.2.3 Bayer Targeted Radiopharmaceuticals Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Targeted Radiopharmaceuticals Product Overview
10.3.3 Lantheus Targeted Radiopharmaceuticals Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 Institute for Radioelements (IRE)
10.4.1 Institute for Radioelements (IRE) Basic Information
10.4.2 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Overview
10.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Market Performance
10.4.4 Institute for Radioelements (IRE) Business Overview
10.4.5 Institute for Radioelements (IRE) Recent Developments
10.5 Radiomedix
10.5.1 Radiomedix Basic Information
10.5.2 Radiomedix Targeted Radiopharmaceuticals Product Overview
10.5.3 Radiomedix Targeted Radiopharmaceuticals Product Market Performance
10.5.4 Radiomedix Business Overview
10.5.5 Radiomedix Recent Developments
10.6 Curium Pharma
10.6.1 Curium Pharma Basic Information
10.6.2 Curium Pharma Targeted Radiopharmaceuticals Product Overview
10.6.3 Curium Pharma Targeted Radiopharmaceuticals Product Market Performance
10.6.4 Curium Pharma Business Overview
10.6.5 Curium Pharma Recent Developments
10.7 Clarity Pharmaceuticals
10.7.1 Clarity Pharmaceuticals Basic Information
10.7.2 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.7.4 Clarity Pharmaceuticals Business Overview
10.7.5 Clarity Pharmaceuticals Recent Developments
10.8 ROTOP
10.8.1 ROTOP Basic Information
10.8.2 ROTOP Targeted Radiopharmaceuticals Product Overview
10.8.3 ROTOP Targeted Radiopharmaceuticals Product Market Performance
10.8.4 ROTOP Business Overview
10.8.5 ROTOP Recent Developments
10.9 Ratio Therapeutics
10.9.1 Ratio Therapeutics Basic Information
10.9.2 Ratio Therapeutics Targeted Radiopharmaceuticals Product Overview
10.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.9.4 Ratio Therapeutics Business Overview
10.9.5 Ratio Therapeutics Recent Developments
10.10 Fusion Pharmaceuticals
10.10.1 Fusion Pharmaceuticals Basic Information
10.10.2 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.10.4 Fusion Pharmaceuticals Business Overview
10.10.5 Fusion Pharmaceuticals Recent Developments
10.11 Perspective Therapeutics
10.11.1 Perspective Therapeutics Basic Information
10.11.2 Perspective Therapeutics Targeted Radiopharmaceuticals Product Overview
10.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.11.4 Perspective Therapeutics Business Overview
10.11.5 Perspective Therapeutics Recent Developments
10.12 RayzeBio
10.12.1 RayzeBio Basic Information
10.12.2 RayzeBio Targeted Radiopharmaceuticals Product Overview
10.12.3 RayzeBio Targeted Radiopharmaceuticals Product Market Performance
10.12.4 RayzeBio Business Overview
10.12.5 RayzeBio Recent Developments
10.13 Alpha-9 Theranostics
10.13.1 Alpha-9 Theranostics Basic Information
10.13.2 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Overview
10.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Market Performance
10.13.4 Alpha-9 Theranostics Business Overview
10.13.5 Alpha-9 Theranostics Recent Developments
10.14 Radiopharm Theranostics
10.14.1 Radiopharm Theranostics Basic Information
10.14.2 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Overview
10.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product Market Performance
10.14.4 Radiopharm Theranostics Business Overview
10.14.5 Radiopharm Theranostics Recent Developments
10.15 Telix Pharmaceuticals
10.15.1 Telix Pharmaceuticals Basic Information
10.15.2 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.15.4 Telix Pharmaceuticals Business Overview
10.15.5 Telix Pharmaceuticals Recent Developments
10.16 Ariceum Therapeutics
10.16.1 Ariceum Therapeutics Basic Information
10.16.2 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Overview
10.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product Market Performance
10.16.4 Ariceum Therapeutics Business Overview
10.16.5 Ariceum Therapeutics Recent Developments
10.17 Aktis Oncology
10.17.1 Aktis Oncology Basic Information
10.17.2 Aktis Oncology Targeted Radiopharmaceuticals Product Overview
10.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product Market Performance
10.17.4 Aktis Oncology Business Overview
10.17.5 Aktis Oncology Recent Developments
10.18 Navidea Biopharmaceuticals
10.18.1 Navidea Biopharmaceuticals Basic Information
10.18.2 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Overview
10.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Market Performance
10.18.4 Navidea Biopharmaceuticals Business Overview
10.18.5 Navidea Biopharmaceuticals Recent Developments
10.19 Nucleus RadioPharma
10.19.1 Nucleus RadioPharma Basic Information
10.19.2 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Overview
10.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product Market Performance
10.19.4 Nucleus RadioPharma Business Overview
10.19.5 Nucleus RadioPharma Recent Developments
10.20 SmartNuclide Biopharma
10.20.1 SmartNuclide Biopharma Basic Information
10.20.2 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Overview
10.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Market Performance
10.20.4 SmartNuclide Biopharma Business Overview
10.20.5 SmartNuclide Biopharma Recent Developments
10.21 TetraKit Technologies
10.21.1 TetraKit Technologies Basic Information
10.21.2 TetraKit Technologies Targeted Radiopharmaceuticals Product Overview
10.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product Market Performance
10.21.4 TetraKit Technologies Business Overview
10.21.5 TetraKit Technologies Recent Developments
11 TARGETED RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Targeted Radiopharmaceuticals Market Size Forecast
11.2 Global Targeted Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Targeted Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Targeted Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Targeted Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Targeted Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Targeted Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Targeted Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Targeted Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Targeted Radiopharmaceuticals by Type (2026-2033)
12.2 Global Targeted Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Targeted Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Targeted Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Targeted Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Targeted Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Targeted Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Targeted Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiopharmaceuticals as of 2024)
Table 10. Global Market Targeted Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Targeted Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Targeted Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Targeted Radiopharmaceuticals Sales by Type (K MT)
Table 26. Global Targeted Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Targeted Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 28. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Targeted Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Targeted Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Targeted Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 32. Global Targeted Radiopharmaceuticals Sales (K MT) by Application
Table 33. Global Targeted Radiopharmaceuticals Market Size by Application
Table 34. Global Targeted Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 35. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Targeted Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Targeted Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 40. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Targeted Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 44. North America Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 50. South America Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Targeted Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 54. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Novartis Basic Information
Table 62. Novartis Targeted Radiopharmaceuticals Product Overview
Table 63. Novartis Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Novartis Business Overview
Table 65. Novartis SWOT Analysis
Table 66. Novartis Recent Developments
Table 67. Bayer Basic Information
Table 68. Bayer Targeted Radiopharmaceuticals Product Overview
Table 69. Bayer Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Bayer Business Overview
Table 71. Bayer SWOT Analysis
Table 72. Bayer Recent Developments
Table 73. Lantheus Basic Information
Table 74. Lantheus Targeted Radiopharmaceuticals Product Overview
Table 75. Lantheus Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Lantheus Business Overview
Table 77. Lantheus SWOT Analysis
Table 78. Lantheus Recent Developments
Table 79. Institute for Radioelements (IRE) Basic Information
Table 80. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Overview
Table 81. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Institute for Radioelements (IRE) Business Overview
Table 83. Institute for Radioelements (IRE) Recent Developments
Table 84. Radiomedix Basic Information
Table 85. Radiomedix Targeted Radiopharmaceuticals Product Overview
Table 86. Radiomedix Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Radiomedix Business Overview
Table 88. Radiomedix Recent Developments
Table 89. Curium Pharma Basic Information
Table 90. Curium Pharma Targeted Radiopharmaceuticals Product Overview
Table 91. Curium Pharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Curium Pharma Business Overview
Table 93. Curium Pharma Recent Developments
Table 94. Clarity Pharmaceuticals Basic Information
Table 95. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 96. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Clarity Pharmaceuticals Business Overview
Table 98. Clarity Pharmaceuticals Recent Developments
Table 99. ROTOP Basic Information
Table 100. ROTOP Targeted Radiopharmaceuticals Product Overview
Table 101. ROTOP Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. ROTOP Business Overview
Table 103. ROTOP Recent Developments
Table 104. Ratio Therapeutics Basic Information
Table 105. Ratio Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 106. Ratio Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Ratio Therapeutics Business Overview
Table 108. Ratio Therapeutics Recent Developments
Table 109. Fusion Pharmaceuticals Basic Information
Table 110. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 111. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Fusion Pharmaceuticals Business Overview
Table 113. Fusion Pharmaceuticals Recent Developments
Table 114. Perspective Therapeutics Basic Information
Table 115. Perspective Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 116. Perspective Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Perspective Therapeutics Business Overview
Table 118. Perspective Therapeutics Recent Developments
Table 119. RayzeBio Basic Information
Table 120. RayzeBio Targeted Radiopharmaceuticals Product Overview
Table 121. RayzeBio Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. RayzeBio Business Overview
Table 123. RayzeBio Recent Developments
Table 124. Alpha-9 Theranostics Basic Information
Table 125. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Overview
Table 126. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Alpha-9 Theranostics Business Overview
Table 128. Alpha-9 Theranostics Recent Developments
Table 129. Radiopharm Theranostics Basic Information
Table 130. Radiopharm Theranostics Targeted Radiopharmaceuticals Product Overview
Table 131. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Radiopharm Theranostics Business Overview
Table 133. Radiopharm Theranostics Recent Developments
Table 134. Telix Pharmaceuticals Basic Information
Table 135. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 136. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Telix Pharmaceuticals Business Overview
Table 138. Telix Pharmaceuticals Recent Developments
Table 139. Ariceum Therapeutics Basic Information
Table 140. Ariceum Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 141. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Ariceum Therapeutics Business Overview
Table 143. Ariceum Therapeutics Recent Developments
Table 144. Aktis Oncology Basic Information
Table 145. Aktis Oncology Targeted Radiopharmaceuticals Product Overview
Table 146. Aktis Oncology Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Aktis Oncology Business Overview
Table 148. Aktis Oncology Recent Developments
Table 149. Navidea Biopharmaceuticals Basic Information
Table 150. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 151. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Navidea Biopharmaceuticals Business Overview
Table 153. Navidea Biopharmaceuticals Recent Developments
Table 154. Nucleus RadioPharma Basic Information
Table 155. Nucleus RadioPharma Targeted Radiopharmaceuticals Product Overview
Table 156. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Nucleus RadioPharma Business Overview
Table 158. Nucleus RadioPharma Recent Developments
Table 159. SmartNuclide Biopharma Basic Information
Table 160. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Overview
Table 161. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. SmartNuclide Biopharma Business Overview
Table 163. SmartNuclide Biopharma Recent Developments
Table 164. TetraKit Technologies Basic Information
Table 165. TetraKit Technologies Targeted Radiopharmaceuticals Product Overview
Table 166. TetraKit Technologies Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. TetraKit Technologies Business Overview
Table 168. TetraKit Technologies Recent Developments
Table 169. Global Targeted Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 170. Global Targeted Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 171. North America Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 172. North America Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 173. Europe Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 174. Europe Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 175. Asia Pacific Targeted Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 176. Asia Pacific Targeted Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 177. South America Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 178. South America Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 179. Middle East and Africa Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 180. Middle East and Africa Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 181. Global Targeted Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K MT)
Table 182. Global Targeted Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 183. Global Targeted Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/KG)
Table 184. Global Targeted Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2033)
Table 185. Global Targeted Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Targeted Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Targeted Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Targeted Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Targeted Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiopharmaceuticals as of 2024)
Table 10. Global Market Targeted Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Targeted Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Targeted Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Targeted Radiopharmaceuticals Sales by Type (K MT)
Table 26. Global Targeted Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Targeted Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 28. Global Targeted Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Targeted Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Targeted Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Targeted Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 32. Global Targeted Radiopharmaceuticals Sales (K MT) by Application
Table 33. Global Targeted Radiopharmaceuticals Market Size by Application
Table 34. Global Targeted Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 35. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Targeted Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Targeted Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 40. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Targeted Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 44. North America Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Targeted Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 50. South America Targeted Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Targeted Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Targeted Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Targeted Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 54. Global Targeted Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Targeted Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Targeted Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Novartis Basic Information
Table 62. Novartis Targeted Radiopharmaceuticals Product Overview
Table 63. Novartis Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Novartis Business Overview
Table 65. Novartis SWOT Analysis
Table 66. Novartis Recent Developments
Table 67. Bayer Basic Information
Table 68. Bayer Targeted Radiopharmaceuticals Product Overview
Table 69. Bayer Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Bayer Business Overview
Table 71. Bayer SWOT Analysis
Table 72. Bayer Recent Developments
Table 73. Lantheus Basic Information
Table 74. Lantheus Targeted Radiopharmaceuticals Product Overview
Table 75. Lantheus Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Lantheus Business Overview
Table 77. Lantheus SWOT Analysis
Table 78. Lantheus Recent Developments
Table 79. Institute for Radioelements (IRE) Basic Information
Table 80. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product Overview
Table 81. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Institute for Radioelements (IRE) Business Overview
Table 83. Institute for Radioelements (IRE) Recent Developments
Table 84. Radiomedix Basic Information
Table 85. Radiomedix Targeted Radiopharmaceuticals Product Overview
Table 86. Radiomedix Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Radiomedix Business Overview
Table 88. Radiomedix Recent Developments
Table 89. Curium Pharma Basic Information
Table 90. Curium Pharma Targeted Radiopharmaceuticals Product Overview
Table 91. Curium Pharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Curium Pharma Business Overview
Table 93. Curium Pharma Recent Developments
Table 94. Clarity Pharmaceuticals Basic Information
Table 95. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 96. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Clarity Pharmaceuticals Business Overview
Table 98. Clarity Pharmaceuticals Recent Developments
Table 99. ROTOP Basic Information
Table 100. ROTOP Targeted Radiopharmaceuticals Product Overview
Table 101. ROTOP Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. ROTOP Business Overview
Table 103. ROTOP Recent Developments
Table 104. Ratio Therapeutics Basic Information
Table 105. Ratio Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 106. Ratio Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Ratio Therapeutics Business Overview
Table 108. Ratio Therapeutics Recent Developments
Table 109. Fusion Pharmaceuticals Basic Information
Table 110. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 111. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Fusion Pharmaceuticals Business Overview
Table 113. Fusion Pharmaceuticals Recent Developments
Table 114. Perspective Therapeutics Basic Information
Table 115. Perspective Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 116. Perspective Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Perspective Therapeutics Business Overview
Table 118. Perspective Therapeutics Recent Developments
Table 119. RayzeBio Basic Information
Table 120. RayzeBio Targeted Radiopharmaceuticals Product Overview
Table 121. RayzeBio Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. RayzeBio Business Overview
Table 123. RayzeBio Recent Developments
Table 124. Alpha-9 Theranostics Basic Information
Table 125. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product Overview
Table 126. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Alpha-9 Theranostics Business Overview
Table 128. Alpha-9 Theranostics Recent Developments
Table 129. Radiopharm Theranostics Basic Information
Table 130. Radiopharm Theranostics Targeted Radiopharmaceuticals Product Overview
Table 131. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Radiopharm Theranostics Business Overview
Table 133. Radiopharm Theranostics Recent Developments
Table 134. Telix Pharmaceuticals Basic Information
Table 135. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 136. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Telix Pharmaceuticals Business Overview
Table 138. Telix Pharmaceuticals Recent Developments
Table 139. Ariceum Therapeutics Basic Information
Table 140. Ariceum Therapeutics Targeted Radiopharmaceuticals Product Overview
Table 141. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Ariceum Therapeutics Business Overview
Table 143. Ariceum Therapeutics Recent Developments
Table 144. Aktis Oncology Basic Information
Table 145. Aktis Oncology Targeted Radiopharmaceuticals Product Overview
Table 146. Aktis Oncology Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Aktis Oncology Business Overview
Table 148. Aktis Oncology Recent Developments
Table 149. Navidea Biopharmaceuticals Basic Information
Table 150. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product Overview
Table 151. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Navidea Biopharmaceuticals Business Overview
Table 153. Navidea Biopharmaceuticals Recent Developments
Table 154. Nucleus RadioPharma Basic Information
Table 155. Nucleus RadioPharma Targeted Radiopharmaceuticals Product Overview
Table 156. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Nucleus RadioPharma Business Overview
Table 158. Nucleus RadioPharma Recent Developments
Table 159. SmartNuclide Biopharma Basic Information
Table 160. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product Overview
Table 161. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. SmartNuclide Biopharma Business Overview
Table 163. SmartNuclide Biopharma Recent Developments
Table 164. TetraKit Technologies Basic Information
Table 165. TetraKit Technologies Targeted Radiopharmaceuticals Product Overview
Table 166. TetraKit Technologies Targeted Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. TetraKit Technologies Business Overview
Table 168. TetraKit Technologies Recent Developments
Table 169. Global Targeted Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 170. Global Targeted Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 171. North America Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 172. North America Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 173. Europe Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 174. Europe Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 175. Asia Pacific Targeted Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 176. Asia Pacific Targeted Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 177. South America Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 178. South America Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 179. Middle East and Africa Targeted Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 180. Middle East and Africa Targeted Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 181. Global Targeted Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K MT)
Table 182. Global Targeted Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 183. Global Targeted Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/KG)
Table 184. Global Targeted Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2033)
Table 185. Global Targeted Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Targeted Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Targeted Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Targeted Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Targeted Radiopharmaceuticals Product Life Cycle
Figure 13. Targeted Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Targeted Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Targeted Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Targeted Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Targeted Radiopharmaceuticals
Figure 19. Global Targeted Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Targeted Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Targeted Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Targeted Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Targeted Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Targeted Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Targeted Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Targeted Radiopharmaceuticals Market Share by Application
Figure 33. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Targeted Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Targeted Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Targeted Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Targeted Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Targeted Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Targeted Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Targeted Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Targeted Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Targeted Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Targeted Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Targeted Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Targeted Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Targeted Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Targeted Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Targeted Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Targeted Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Targeted Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Targeted Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Targeted Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Targeted Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Targeted Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Targeted Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Targeted Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Targeted Radiopharmaceuticals Product Life Cycle
Figure 13. Targeted Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Targeted Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Targeted Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Targeted Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Targeted Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Targeted Radiopharmaceuticals
Figure 19. Global Targeted Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Targeted Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Targeted Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Targeted Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Targeted Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Targeted Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Targeted Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Targeted Radiopharmaceuticals Market Share by Application
Figure 33. Global Targeted Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Targeted Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Targeted Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Targeted Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Targeted Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Targeted Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Targeted Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Targeted Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Targeted Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Targeted Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Targeted Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Targeted Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Targeted Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Targeted Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Targeted Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Targeted Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Targeted Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Targeted Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Targeted Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Targeted Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Targeted Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Targeted Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Targeted Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Targeted Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Targeted Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Targeted Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Targeted Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Targeted Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Targeted Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Targeted Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
